ObjectiveThis annual conference aims to keep legal practitioners working with the pharmaceutical sector up-to-date on the latest regulatory developments, legislative initiatives and case law. A particular focus will be on implications for the sector of recent EU activities in the fields of competition law, intellectual property and pharmaceutical law.Key topicsCompetition law Update on activities from the European CommissionImpact of recent competition law decisions in the US and EuropeOutcome of national judicial decisions on supplementary protection certificate and second medical useIntellectual property law and the fight against counterfeiting of medicinal products Implementation of the Directive on Falsified Medicinal ProductsTackling pharmaceutical crimes in EuropeEU pharmaceutical law round-up Update on recent activities from the EMA and the European CommissionClinical trials and transparency policies: how to submit clinical reports to the EMA?Update on medical devices and in-vitro diagnosticsAccess to new medicinal products and price containment policies in Member States Market exclusivity for rare diseases: recent case law from the CJEUImpact of recent initiatives and CJEU decisions on parallel importsWho should attend?In-house counsel, lawyers in private practice, lawyers in national ministries and authorities dealing with regulation of the sector.